Adamas Pharmaceuticals, Inc.

ADMS | NASDAQ | 1 Followers
$8.22 0.00% $0.00
Follow
Overview Metrics Financials

Key Metrics TTM

Valuation

Market cap.

$0

Enterprise Value

$58M

Price to Earnings

-5.04

Price to Sales

0.00

Price to Book

-5.78

Price to Cash Flow

0.00

Profitability

Return on Assets

-47.82%

Return on Equity

225.69%

Return on Invested Capital

-49.72%

Gross Margin

97.26%

Operating Margin

-59.31%

Net Margin

-77.09%

Liquidity

Quick Ratio

3.00

Current Ratio

3.20

Cash Ratio

2.06

Inventory Turnover

0.28

Asset Turnover

0.62

Total Liabilities

N/A

Solvency

Debt to Assets

1.08

Debt to Equity

N/A

Interest Coverage

-3.34

Equity Ratio

N/A

Long-term Debt to Cap.

1.65

Altman Z-Score

N/A
Don't have an account? Join us

Log in to Bulios

Continue with Google
Continue with Apple
Continue with Facebook
Or use email and password
visibility_off
Reset password
Already a member? Log in

Create Bulios profile

Continue with
Or use email and password
You can use lowercase letters, numbers, and underscores
visibility_off

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools
We use cookies to improve your experience on our site.
Menu StockBot
Tracker
Upgrade